The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for SHARN Anesthesia sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
SHARN Anesthesia Inc (SHARN) is a medical device company that supplies anesthesia products. The company offers products such as exchangers, endotracheal tubes, disposable stylets, disposable laryngoscopes, fiber optic laryngoscope handles and blades, MR conditional laryngoscopes, laryngoscope sets, lamps and accessories, temperature management, BP cuffs and sphygmomanometers, pulse oximeters and others. It provides anesthesia essential products such as nerve stimulators, machine essentials, breathing circuits, masks, block needles, oxygen delivery and patient positioning. SHARN also offers sterilization indicator tapes, anesthesia screen, clark socket and clamps. The company’s products caters to anesthesia and central sterile departments. SHARN is headquartered in Kent County, Michigan, the US.
The key metrics of SHARN Anesthesia related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As SHARN Anesthesia is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as SHARN Anesthesia.
For a detailed understanding of the performance of SHARN Anesthesia, buy the report here.